CD8A and neoplasm: While CD200-/- mice were cured of tumor growth using conventional chemotherapy with a combination of paclitaxel and anti-VEGF antibody, this treatment was not affected by anti-CD4 or anti-CD8 treatment, and did not lead to development of any immunity to re-challenge with the same tumor [5].